Cowen Prime Advisors LLC - HTG MOLECULAR DIAGNOSTICS IN ownership

Back to all holdings Add to watchlist

HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H203. A total of 24 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Links
Filings
External links
Quarter-by-quarter ownership
Cowen Prime Advisors LLC ownership history of HTG MOLECULAR DIAGNOSTICS IN
ValueSharesWeighting
Q1 2022$462,000
-85.6%
332,197
-44.0%
0.19%
-82.3%
Q4 2021$3,215,000
-19.4%
593,133
-15.1%
1.09%
-26.3%
Q3 2021$3,989,000
+20.4%
698,533
+22.5%
1.48%
+23.5%
Q2 2021$3,314,000–570,333–1.20%–
 Download
Other shareholders

There were no reported owners of HTG MOLECULAR DIAGNOSTICS IN in Q4 2021.

NameSharesValueWeighting ↓
View complete list of HTG MOLECULAR DIAGNOSTICS IN shareholders